Global Pharmaceuticals & Biotech Big Green Snowflakes

Inhibikase Therapeutics

Market Cap: US$124.4m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

GRI Bio

Market Cap: US$3.9m

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.

Candel Therapeutics

Market Cap: US$272.8m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

Quoin Pharmaceuticals

Market Cap: US$4.3m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

Anavex Life Sciences

Market Cap: US$881.3m

Operates as a biopharmaceutical company.

Addex Therapeutics

Market Cap: CHF 5.7m

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.

Oculis Holding

Market Cap: US$899.7m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

Oruka Therapeutics

Market Cap: US$601.1m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Dottikon ES Holding

Market Cap: CHF 4.1b

Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries worldwide.

ValiRx

Market Cap: UK£2.8m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Akanda

Market Cap: US$2.4m

Through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products.

Zelluna

Market Cap: NOK 275.8m

Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.

Diamyd Medical

Market Cap: SEK 1.6b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Bio-Rad Laboratories

Market Cap: US$7.5b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Bolt Biotherapeutics

Market Cap: US$9.7m

A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.

Adaptimmune Therapeutics

Market Cap: US$13.0m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

Ligand Pharmaceuticals

Market Cap: US$3.2b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

OncoZenge

Market Cap: SEK 86.6m

A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.

Perspective Therapeutics

Market Cap: US$250.3m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Equillium

Market Cap: US$108.9m

A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.

Denali Therapeutics

Market Cap: US$2.2b

A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

D. Western Therapeutics Institute

Market Cap: JP¥4.7b

A biotechnology company, focuses on discovery and development of various drugs.

Tarsons Products

Market Cap: ₹16.7b

Manufactures and trades in scientific plastic labware products in India and internationally.

Evoq Remedies

Market Cap: ₹93.9m

Engages in the pharmaceutical business in India.

Porton Pharma Solutions

Market Cap: CN¥14.0b

Provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial.

Chongqing Taiji Industry(Group)Ltd

Market Cap: CN¥12.4b

Develops, produces, and sells traditional Chinese and modern medicine products in China and internationally.

Sanai Health Industry Group

Market Cap: HK$68.0m

An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Harbin Pharmaceutical Group

Market Cap: CN¥9.3b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

Welcure Drugs and Pharmaceuticals

Market Cap: ₹1.1b

Engages in trading of agriculture products in India.

Techno Drugs

Market Cap: ৳4.6b

Manufactures and sells human and veterinary medicines in Bangladesh and internationally.

China Traditional Chinese Medicine Holdings

Market Cap: HK$10.9b

China Traditional Chinese Medicine Holdings Co.

Ildong Holdings

Market Cap: ₩105.2b

Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.

Viridian Therapeutics

Market Cap: US$1.7b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Psyence Group

Market Cap: CA$2.3m

A life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma.

Purple Biotech

Market Cap: ₪17.5m

A clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.

Exact Sciences

Market Cap: US$10.5b

Provides cancer screening and diagnostic test products in the United States and internationally.